🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11702+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11702 recruiting trials

NARecruitingNCT06523569

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

👨‍⚕️ Priya M Freaney, MD, Northwestern University📍 1 site📅 Started Nov 2024View details ↗
Phase 2, PHASE3RecruitingNCT05893888

Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell Carcinoma

🏥 Privo Technologies📍 4 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06715228

Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep Apnea

👨‍⚕️ Ali Ismail, lecturer, Cairo University📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06162884

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

👨‍⚕️ Samuel Weigt, MD, UCLA Division of Pulmonary, Critical Care, and Hospitals📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06447987

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

👨‍⚕️ Ibrahim Aldoss, City of Hope Medical Center📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT05582993

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

👨‍⚕️ Study Director, Takeda📍 15 sites📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06311331

Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)

🏥 Restor3D📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06750419

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 8 sites📅 Started Nov 2024View details ↗
NAEnrolling by InvitationNCT06578117

Statistical Learning as a Novel Intervention for Cortical Blindness

🏥 University of Rochester📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06663358

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

🏥 Chiesi Farmaceutici S.p.A.📍 10 sites📅 Started Nov 2024View details ↗
RecruitingNCT06794489

Longitudinal Biomarkers With Selected Outcome Measures In CMT

🏥 University Medical Center Goettingen📍 1 site📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06488924

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

🏥 JCR Pharmaceuticals Co., Ltd.📍 3 sites📅 Started Nov 2024View details ↗
RecruitingNCT06692894

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

🏥 University of Vermont📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT06886282

Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease

🏥 National Cancer Institute, Naples📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06926127

Genomic Profiling of Genetic and Rare Diseases

👨‍⚕️ Giovanni Scambia, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06266403

Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications

👨‍⚕️ Jimin Lee, PhD, The Pennsylvania State University📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06615492

Routine vs On-demand ECMO for Lung Transplantation

🏥 Centre hospitalier de l'Université de Montréal (CHUM)📍 4 sites📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06703801

Evaluation of the Progression of Disease and Health-related Quality of Life in Patients With Pulmonary Hypertension: A Local Clinic-based Registry

🏥 Chinese University of Hong Kong📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06614777

Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

👨‍⚕️ Juliette Mazereeuw-hautier, MD, University Hospital of Toulouse📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06121180

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

👨‍⚕️ Ahmad Tarhini, MD, PHD, Moffitt Cancer Center📍 4 sites📅 Started Nov 2024View details ↗
← PreviousPage 212 of 586Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →